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Abstract Small-angle X-ray scattering was used to investigate
a complex state of apocalmodulin induced by the binding of a
Ca2+/calmodulin-dependent protein kinase IV calmodulin target
site. Upon binding of the peptide, the molecular weight for
apocalmodulin increased by 8.4%, which provides direct evidence
for the formation of a calmodulin/target peptide complex.
Comparison of the radius of gyration and Kratky plots of the
apocalmodulin/peptide complex with those of apocalmodulin
indicates that the overall conformation remains unchanged but
the flexibility of the central linker decreases. An analysis of
residue pairs between calmodulin and the target peptides suggests
that the complex formation is induced by electrostatic interac-
tions and subsequent van der Waals interactions. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
Calmodulin (CaM) is a ubiquitous Ca2-binding protein of
148 residues that regulates a variety of physiological processes
in a Ca2-dependent manner [1]. The regulation is achieved
through the interaction of Ca2-saturated CaM (Ca2/CaM)
with a large number of target enzymes [2^4]. The Ca2/CaM
molecule adopts a dumbbell-shaped structure in which the
two lobes are connected by a highly £exible linker [5^11],
while the structure of Ca2/CaM complexed with a peptide
from target enzymes takes a compact globular shape caused
by the bending of the central linker [12^17]. These structural
studies suggest that the £exibility of the central linker and the
two hydrophobic patches in Ca2/CaM play an important
role in target recognition.
Although most published works were done in the presence
of saturating Ca2 concentrations, there are some target pro-
teins, such as melittin, seminal plasmin [18], mastoparan
[19,20], the CaM-binding domain of cyclic nucleotide phopho-
diesterase (PDE1A2) [21] and smooth muscle myosin light
chain kinase (smMLCK) RS20 [22], that signi¢cantly inter-
acted also with Ca2-free CaM (apocalmodulin, apoCaM)
or only with the apoCaM as neuromodulin [23]. Recently, it
is presumed that apoCaM interacts with these peptides utiliz-
ing di¡erent binding motifs such as the IQ motif observed in
neuromodulin. However, little is known about the mechanism
of apoCaM’s interaction with its target peptides and the over-
all conformation of apoCaM/peptide complexes. What is the
physiological role of apoCaM/peptide complexes? It has been
hypothesized that the apoCaM/RS20 complex is an intermedi-
ate in the formation of the Ca2/CaM/RS20 complex [24].
The aim of the present study is to investigate the complex
state in apoCaM induced by the binding of a peptide with
Ca2-dependent CaM-binding motifs by small-angle X-ray
scattering (SAXS). We used a 19-residue peptide encompass-
ing the Ca2/CaM-dependent protein kinase IV (human) CaM
target site as a natural target-binding domain of CaM [25^27].
This peptide has been classi¢ed as a 1-5-8-14 motif [28]. The
present results provide the ¢rst detailed SAXS evidence for
the formation of apoCaM/peptide complex.
2. Materials and methods
2.1. Materials
A 19-residue peptide having the sequence RRKLKAAVKAV-
VASSRLGS corresponding to the CaM-binding domain (residues
323^341) of the Ca2/CaM-dependent protein kinase IV (human) (re-
ferred to as the CaMKIV-19 peptide) was synthesized on an Applied
Biosystems Model 431A Peptide synthesizer using the general proce-
dure and puri¢ed by reverse phase high-performance liquid chroma-
tography. Bovine brain CaM was prepared and puri¢ed by the exact
same methods as previously described [29].
2.2. SAXS measurements
The basic medium used for the SAXS measurements was 50 mM
Tris^HCl, pH 7.6, and 120 mM NaCl. Ca2-free proteins were placed
in 1 mM EDTA. The apoCaM/CaMKIV-19 peptide complex was
prepared by mixing the protein with a 1.05-fold molar excess of the
peptide. The protein concentrations were 7.5, 10.0, 12.5, 15.0, 17.5
and 20.0 mg/ml. The concentration of proteins was determined by
the method of Lowry et al. [30].
The measurements were performed using synchrotron orbital radi-
ation with an instrument for SAXS installed at BL-10C of Photon
Factory, Tsukuba [31]. An X-ray wavelength of 1.488 Aî was selected.
The samples were contained in a mica cell with a volume of 70 Wl, and
the temperature was maintained at 25.0 þ 0.1‡C by circulating water
through the sample holder. The reciprocal parameter, s, equal to
2 sin a/V, was calibrated by the observation of a peak from dried
chicken collagen, where 2a is the scattering angle and V is the X-ray
wavelength. Scattering data were collected for 200 s at various protein
concentrations.
Two methods of data analysis were used. The ¢rst method was that
of Guinier [32]. The scattering intensity I(s, c) measured as a function
of s at a ¢nite protein concentration, c, is given by:
Is; c  I0; cexpf34Z2=3Rgc2s2g 1
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where I(0, c) is the scattering intensity at s = 0 and Rg(c) is the radius
of gyration at a concentration, c. In the dilute limit, I(0, c) is given by:
Kc=I0; c  1=M  2A2c T 2
where K is a constant, M is the molecular weight of the protein,
and A2 is the second virial coe⁄cient. In the dilute limit, Rg is given
by:
R2g  R203Bif c T 3
where R0 is the radius of gyration at in¢nite dilution and Bif is the
parameter of interparticle interference [33]. Using Eqs. 2 and 3, we
estimated the four parameters M, A2, R0 and Bif . For the analysis, the
range of s (Aî 31) was 4.4U1033 to 1.24U1032 for all samples mea-
sured. The second method was that of Kratky [34], which is de¢ned
by the plot of s2I(s, 0) versus s (the Kratky plot). The Kratky plot
provides the structural characteristics (e.g. molecular shape) of a chain
polymer [34^37] and a biopolymer [38]. For the analysis, all data to
s = 0.06 Aî 31 were used.
3. Results
3.1. Guinier region of the scattering pro¢le
Examples of Guinier plots (ln I(s) versus s2) for apoCaM in
the absence and presence of target peptide over the concen-
tration series are shown in Fig. 1. In all of the samples studied
here, there is no evidence of any upward curvature at low s
values in the Guinier plots, which indicates that the data are
free from the aggregation of samples. The values of Kc/I(0, c)
evaluated from the intercepts of the Guinier plots are shown
as a function of protein concentration in Fig. 2. Plots in Fig. 2
are also linear over the entire concentration range, and the
values of [Kc/I(0, c)]c0 extrapolated to in¢nite dilution for
apoCaM in the absence and presence of target peptide have
the inverse molecular weight appropriate for the soluble
monomer. The molecular weights M and the second virial
coe⁄cients A2 were calculated using Eq. 2 and compiled in
Table 1. The value of M increased about 8.4% in the presence
of 1 mol of the target peptide, whose increment almost cor-
responds to the molecular weight of 1 mol of the target pep-
tide (about 11.9%), while the value of A2 decreased about
30%. The increase in the molecular weight provides the direct
evidence that a complex is formed between apoCaM and the
target peptide even in the absence of Ca2.
Radii of gyration at ¢nite concentrations were calculated
from the slopes of the Guinier plots using Eq. 1 and are
shown as a function of protein concentration in Fig. 3. The
linear increase with decreasing protein concentration was ob-
served. The slopes of these lines, which arise from interparticle
interference e¡ects, represent a virial coe⁄cient [32].
Table 1 compiles the values of R0 and Bif . The formation of
a complex with the target peptide increases the radius of gy-
ration of apoCaM by 1.0 þ 0.3 Aî in comparison with that in
the absence of target peptide. Furthermore, the formation of
the complex decreases the value of Bif by 16%.
3.2. Kratky region of the scattering pro¢le
Fig. 4 shows the Kratky plots for apoCaM in the absence
and presence of target peptide. The Kratky plot for apoCaM
without the target peptide is characterized by the presence of a
broad asymmetric maximum near s = 0.0153 Aî 31, indicating
that apoCaM without peptide adopts a dumbbell-shaped
structure. In the presence of target peptide, the changes in
the Kratky plot are very slight, i.e. the position of the max-
imum shifts to the low value of s = 0.0139 Aî 31. The results
indicate that the overall size of the complex increases but
apoCaM still preserves a dumbbell-shaped structure even in
the presence of target peptide.
4. Discussion
4.1. Solution structure of apoCaM/CaMKIV-19 peptide
complex
The SAXS analysis shows that the values of M and R0
Table 1
Molecular weight (M) and second virial coe⁄cient (A2), radius of gyration at in¢nite dilution (R0), parameter of interparticle interference (Bif )
and center-to-center distance between two lobes (L) for CaM at pH 7.6
1033M 104A2 (mol cm3/g2) R0 (Aî ) 1013Bif (cm5/g) La (Aî )
ApoCaM 16.7 þ 0.8 3.1 þ 0.3 21.2 þ 0.3 6.8 þ 0.6 33.2 þ 0.8
ApoCaM/CaMKIV-19 peptide 18.1 þ 0.9 1.9 þ 0.2 22.2 þ 0.3 5.7 þ 0.5 35.7 þ 0.8
4Ca2/CaM [12,52] 16.7 þ 0.8 2.1 þ 0.2 21.5 þ 0.3 4.7 þ 0.4 33.9 þ 0.8
aRd = 13.2 Aî was assumed [33].
Fig. 1. Guinier plots for apoCaM (A3) and apoCaM/CaMKIV-19
peptide complex (A) at various protein concentrations: (1) 7.5
mg/ml; (2) 10.0 mg/ml; (3) 12.5 mg/ml; (4) 15.0 mg/ml; (5) 17.5
mg/ml; (6) 20.0 mg/ml.
FEBS 24805 17-4-01
Y. Izumi et al./FEBS Letters 495 (2001) 126^130 127
increase, while A2 and Bif decrease, upon binding of 1 mol of
the target peptide. The most straightforward interpretation
for the increase of M and R0 is that a complex is created
between apoCaM and CaMKIV-19 peptide upon binding of
1 mol of the peptide. The results for the Kratky plots indicate
that apoCaM with the peptide essentially adopts a dumbbell-
shaped structure similar to that without peptide, although its
overall size becomes larger than that of the apoCaM without
peptide.
Based on the dumbbell-shaped structure, the center-to-cen-








[39], where Rd is the radius of gyration of each lobe. We used
the experimental value of Rd = 13.2 þ 0.2 Aî for the F34 frag-
ment in the Ca2-free form [33]. Using R0 in Table 1, the
values of L calculated for apoCaM were compiled in Table
1. The 1 Aî increase in R0, induced by binding of 1 mol of the
target peptide, corresponds to the 2.5 Aî increase in L. The
increase in L is consistent with the shift of the peak from
0.0153 to 0.0139 Aî 31 in the Kratky plots. What is the mean-
ing of the increase in L? As reported previously [40^42], the
two lobes in apoCaM tumble independently in solution and
the Ca2-binding loops (residues 20^31, 56^67, 93^104 and
129^140) are partially unstructured. The increase in R0 in-
duced upon binding of Ca2 is rather small as shown in Table
1, although it leads to a drastic decrease in the loop £exibility.
It is thought that in the absence of Ca2, the loop £exibility
hardly changes upon binding of target peptide. Therefore, the
increase in L induced by the binding of peptide suggests a
reduction of the linker £exibility.
In order to specify the location of the peptide in the com-
plex, a multibody model depicted in the inset of Fig. 5 was
applied. Because the global conformation of apoCaM consists
Fig. 2. Zimm plots for apoCaM (a) and apoCaM/CaMKIV-19 pep-
tide complex (b).
Fig. 3. The square of the radius of gyration, R2g, for apoCaM (a)
and apoCaM/CaMKIV-19 peptide complex (b) as a function of the
protein concentration.
Fig. 4. Kratky plots for apoCaM (A3) and apoCaM/CaMKIV-19
peptide complex (A).
Fig. 5. The rotational angle (a) dependence of R0 values calculated
for a multibody model shown in the inset, in which 1, 2 and P rep-
resent the N- and C-terminal lobes and the peptide, respectively.
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of two quite separate but compact globular domains, it in-
duces the increase in L upon binding of the peptide. More-
over, we assume that, when bound to apoCaM, the peptide is
only partially helical, as suggested by recent studies [21,22].
The radius of gyration of the complex, R0, making no as-
sumption about shape [43], is :
M1 M2 M3R20 
M1R21  L2G1 M2R22  L2G2  1pcM3R23  L2G3
where Mn and Rn are the molecular weight and the radius of
gyration of body n, respectively, and LGn is the center-to-cen-
ter distance between the complex and the body n. Here n = 1,
2 and 3 represent the N- and C-terminal lobes and the pep-
tide, respectively. The location of the peptide can then be
de¢ned by a rotational angle around the center of gravity of
one lobe, a. The calculated values of R0 were plotted as a
function of a in Fig. 5. The experimental value of R0 for
the complex, 22.2 Aî , was reproduced, when the peptide lo-
cates at aV60‡. Furthermore, the Kratky plots for this model
were calculated using the well-known Debye formula [44], in
which each body was described by the Guinier approximation
[32]. The characteristics in the Kratky plots shown in Fig. 4
were reproduced again, when the peptide locates at aV60‡.
These results suggest that the peptide interacts with one lobe
of apoCaM at aV60‡, while in order to interact with both
lobes of apoCaM, the peptide has to locate at aV41‡.
4.2. ApoCaM/CaMKIV-19 peptide interactions
In order to discuss the interactions between the target pep-
tide and one lobe of apoCaM, we assume that the peptide
interacts solely with the C-terminal lobe of apoCaM. The
binding of apoCaM to the CaMKIV-19 peptide resembles
the only well-characterized apoCaM/peptide interaction, that
of the apoCaM/neuromodulin peptide complex [45,46]. It also
resembles the interaction of apoCaM/PDE peptide [21] as well
as apoCaM/smMLCK RS20 [22,24]. Furthermore, it is
thought that in these complexes, the C-terminal lobe of apo-
CaM bound to the target peptide adopts a semi-open confor-
mation whereas the N-terminal lobe of apoCaM is completely
closed [45].
A comparison between the neuromodulin IQ motif and
Ca2-dependent CaM-binding motifs reveals little homology.
Fig. 6 shows the putative residue pairs between a target pep-
tide and apoCaM [15^17,21,48]. Here we noted four residues
of M109, L112, E114 and K115 of the C-terminal lobe of
CaM which interact with Q40 and R44 of the IQ motif [47].
Moreover, these residues of M109, L112, E114 and K115
locate at aV60‡. We searched for the residue pairs on typical
Ca2-dependent CaM-binding motifs which interact with
these residues of CaM. Both apoCaM and Ca2/CaM bind
to the same region of these motifs, as suggested by the SAXS
analysis and a previous study [48]. We found a common fea-
ture at the location of residues on the binding motifs. That is,
the residues at 0 and 4, using numbering based on the motifs,
have roles in binding with the C-terminal lobe of apoCaM. As
M109 and L112 of apoCaM are largely buried inside the lobe
[40^42], i.e. the lobe is completely closed, these residues are
exposed on the surface of the lobe by the complex formation.
For this reason, it is thought that the C-terminal lobe of
apoCaM adopts a semi-open conformation in the complex
state. The present results suggest that the semi-open confor-
mation does not pre-exist in the C-terminal lobe of apoCaM
but is induced by the binding of the target peptide [49,50]. The
residues E114 and K115 of apoCaM would interact with the
Fig. 6. Residue pairs predicted for apoCaM with a neuromodulin IQ motif (A), residue pairs observed for Ca2-dependent CaM binding motifs
which interact with M109, L112 and E114 of CaM (B), and putative residue pairs for apoCaM with the CaMKIV peptide, suggesting that cy-
clic nucleotide PDE1A2 peptide also interacts with apoCaM in a similar fashion (C). The underlined residues on Ca2-dependent CaM binding
motifs could play a key role in the interaction with apoCaM.
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peptide prior to exposure above hydrophobic residues on its
surface because these residues are located on the surface of the
C-terminal lobe of apoCaM.
Thus, the decrease in A2 and Bif could be due to the electro-
static and van der Waals interactions between apoCaM and
the peptide. It is likely that apoCaM binds to the target pep-
tide, utilizing a binding motif such as the IQ motifs and non-
contiguous binding sites [51]. Moreover, it is presumed that
smMLCK RS20 and cyclic nucleotide PDE1A2 peptide also
interact with apoCaM in a similar manner. However, a com-
plete understanding of the mechanism of apoCaM’s interac-
tion with its target peptide awaits determination of the three-
dimensional structure of apoCaM complexed with its target
peptide.
4.3. Conclusion
The present SAXS results provide strong evidence that
apoCaM binds the CaMKIV-19 peptide in the absence of
Ca2 and the overall conformation of apoCaM remains un-
changed upon binding of the peptide except for the decrease
of the £exibility of the central linker. An analysis of residue
pairs between CaM and the target peptides suggests that the
complex formation is induced by electrostatic interactions and
subsequent van der Waals interactions, which correspond to
the decrease of A2 and Bif .
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